K. Qvortrup et al. / Tetrahedron Letters 50 (2009) 5613–5616
5615
Figure 3. Structure of dropcast samples. (A) Optical microscope image showing small wires of TTF–PDI 6, created by the receding of the drop of toluene during evaporation.
(B) AFM image of a single wire. (C) The structure of a film dropcast from a chloroform solution. The white lines in B and C denote the locations of the height profile cross-
sections shown in D and E, respectively.
13.9 mmol) in dry MeOH (30 mL) was added via syringe over
0.5 h. The reaction mixture was stirred for another 0.5 h, then 2-chlo-
roethanol (3.32 mL, 49.5 mmol) was added and stirring was contin-
ued overnight. The mixture was evaporated to dryness, and the
residue was subjected to column chromatography (SiO2, gradient
elution: CH2Cl2 ? CH2Cl2/MeOH, 95:5), affording 3 (3.6 g, 68%) as a
dark-red semi-solid. 1H NMR (300 MHz, CDCl3): d = 2.39 (s, 6H,
2ÂSCH3), 2.43 (s, 3H, SCH3), 2.52 (br s t, J = ca. 6 Hz, 1H, CH2OH),
2.91 (t, J = 5.9 Hz, 2H, SCH2), 3.69 (br s dt, J = 5.9 Hz, ca. 6 Hz, 2H,
CH2OH); 13C NMR (75 MHz, CDCl3): d = 19.3 (two overlapping), 19.4,
39.3, 60.1, 110.3, 111.7, 122.7, 127.5, 127.7, 133.4; MS (FAB): m/z
418 [M+]; HRMS (FAB): found: m/z 417.8795 [M+], C11H14OS8
requires: m/z 417.8810.
(2 mL) at rt, after which CuSO4Á5H2O (3.0 mg, 0.012 mmol) and
ascorbic acid (4.2 mg, 0.024 mmol) were added. The solution was
stirred at rt for 12 h followed by evaporation of the solvent in vacuo.
Column chromatography (SiO2, CH2Cl2 followed by 5% v/v MeOH in
CH2Cl2) gave the product 5 as an orange solid (100 mg, 85%). Mp
113–114.5 °C. 1H NMR (300 MHz, CDCl3): d = 2.43 (s, 6H, 2 Â SCH3),
2.48 (s, 3H, SCH3), 3.33 (t, J = 6.6 Hz, 2H, SCH2), 4.62 (t, J = 6.6 Hz, 2H,
CH2N), 7.34 (m, 1H, Ph), 7.43 (m, 2H, Ph), 7.84 (m, 2H, Ph), 7.97 (s,
1H, triazole-H); 13C NMR (75 MHz, CDCl3): d = 19.4 (three overlap-
ping), 35.9, 49.9, 109.5, 112.8, 120.6, 121.1, 125.9, 127.6, 127.7,
128.4, 129.0, 130.7, 134.0, 147.9; MS (FAB): m/z 545 [M+]; HRMS
(FAB): found: m/z 544.9328 [M+], C19H19N3S8 requires: m/z
544.9345.
2-(2-Azidoethylthio)-3,6,7-tris(methylthio)tetrathiafulvalene (4):
TTF-alcohol 3 (300 mg, 0.716 mmol) was dissolved in dry DMF
(20 mL), and then diphenyl phosphoryl azide (DPPA) (0.77 mL,
3.58 mmol) was added. The mixture was cooled on an ice bath,
and DBU (0.11 mL, 0.72 mmol) was added. After stirring for 4 h un-
der nitrogen at rt, sodium azide (0.23 g, 3.58 mmol) was added.
The reaction mixture was stirred at rt for another 24 h then
washed with water, and the organic layer dried (Na2SO4), filtered,
and concentrated in vacuo. Column chromatography (SiO2, CH2Cl2)
of the residue afforded 4 (254 mg, 80%) as an orange oil. 1H NMR
(300 MHz, CDCl3): d = 2.43 (s, 6H, 2ÂSCH3), 2.45 (s, 3H, SCH3),
2.95 (t, J = 6.8 Hz, 2H, SCH2), 3.51 (t, J = 6.8 Hz, 2H, CH2N3); 13C
NMR (75 MHz, CDCl3): d = 19.3 (three overlapping), 35.2, 50.8,
110.3, 112.1, 122.3, 127.6, 127.8, 133.1; one overlapping signal;
MS (FAB): m/z 443 [M+]; HRMS (FAB): found: m/z 442.8900 [M+],
C11H13N3S8 requires: m/z 442.8875.
TTF–PDI dyad (6): The TTF-azide 4 (40 mg, 0.090 mmol) and al-
kyne-functionalized PDI 1 (50.0 mg, 0.082 mmol) were dissolved
in DMF (5 mL) at rt to afford a deep-red-colored suspension. Then
CuSO4Á5H2O (1.0 mg, 0.004 mmol) and ascorbic acid (1.4 mg,
0.008 mmol) were added. The mixture was stirred at rt for 12 h, after
which the solvent was removed in vacuo. The crude product was
purified by column chromatography (SiO2, CH2Cl2 followed by 5%
v/v MeOH in CH2Cl2). A red solid was isolated and redissolved in
CH2Cl2 (3 mL). The pure product was precipitated from this solution
by addition of MeOH. TTF–PDI 6 was isolated as a dark-red solid
(27 mg, 31%). Mp >150 °C (decomp.). 1H NMR (300 MHz, CDCl3):
d = 0.83 (t, J = 6.7 Hz, 6H, CH((CH2)5CH3)2), 1.23–1.39 (m, 16H,
CH(CH2(CH2)4CH3)2), 1.84–1.89 and 2.22–2.34 (2Âm, 2Â2H,
CH(CH2(CH2)4CH3)2), 2.36 (s, 3H, SCH3), 2.37 (s, 3H, SCH3), 2.44 (s,
3H, SCH3), 3.26 (t, J = 6.7 Hz, 2H, SCH2), 4.75 (t, J = 6.7 Hz, 2H,
SCH2CH2N), 5.13–5.21 (m, 1H, NCH(C6H13)2), 5.53 (s, 2H, NCH2),
7.93 (s, 1H, triazole-H), 8.29–8.54 (m, 8H, PDI-H); MS (FAB): m/z
1053 [M+H+]; HRMS (FAB): found: m/z 1053.1715 [M+H+],
C51H51O4N5S8 requires: m/z 1053.1707.
2,3,6-Tris(methylthio)-7-[2-(4-phenyl-1H-1,2,3-triazol-1-yl)ethyl-
thio]tetrathiafulvalene (5): TTF-azide 4 (100 mg, 0.23 mmol) and
phenylacetylene (0.03 mL, 0.27 mmol) were dissolved in DMF